Volume 14, Number 3—March 2008
Research
Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel
Table 2
Comparison of patients included in the current study, patients tested for NTM, and patients not tested for NTM*
| Parameter | Patients included in the current study (n = 186) | Patients tested for NTM (n = 265) | Patients not tested for NTM (n = 203) | p value |
|---|---|---|---|---|
| Age (mean ± SD) | 20.51 ± 10.40 | 20.22 ± 10.53 | 13.99 ± 10.70 | 0.0001 |
| Sex, F/M | 74/112 | 105/160 | 86/117 | 0.54 |
| Hemoptysis | 22 | 23 | 4 | 0.002 |
| FEV1, L/s (mean ± SD) | 67.90 ± 22.09 | 65.18 ± 21.69 | 82.94 ± 16.20 | 0.0001 |
| Pancreatic insufficiency | 135 | 151 | 131 | 0.09 |
| Hospitalization, d (mean ± SD) | 21.77 ± 28.54 | 23.80 ± 32.44 | 8.44 ± 14.03 | 0.0001 |
| Administration of antimicrobial agents, d (mean ± SD) | 22.66 ± 47.51 | 19.98 ± 45.52 | 2.30 ± 10.28 | 0.0001 |
| Azithromycin | 104 | 114 | 51 | 0.001 |
| Ibuprofen | 7 | 15 | 6 | 0.16 |
| Insulin | 17 | 20 | 9 | 0.16 |
| Systemic steroids | 13 | 37 | 19 | 0.12 |
| Inhaled steroids | 96 | 106 | 105 | 0.01 |
*NTM, nontuberculous mycobacteria; SD, standard deviation; FEV1, forced expiratory volume in 1 s.


